Precision Oncology

Genetic and genomic testing are playing an increasingly important role in all phases of diagnostic and treatment of cancer. They form the basis of Precision Oncology, but these technologies raise important bioinformatics and laboratory challenges.

Ophiomics – Precision Medicine optimised a method to develop novel genetic and genomic tests that allows the quick implementation of genomic tests in an efficient, quality controlled and producing easy-to-interpret clinically relevant result. This  approach is based on two components – proprietary genomic analysis software (OphiDX®) and in the optimisation of laboratory procedures, particularly for Liquid Biopsies. We use this approach to develop the Precision Oncology Portfolio of the Centro de Medicina Laboratorial Germano de Sousa, available in Portugal and several other countries.